Kohjin Bio Co., Ltd.
Status: Publicly traded
Direct answer
Kohjin Bio Co., Ltd. is publicly traded on JPX under the ticker 177A.T.
Kohjin Bio Co., Ltd. manufactures and sells animal blood, sera, tissue culture media, agar media for microorganism tests, in-vitro diagnostic agents, and cosmetics. The company offers tissue culture mediums for virus and recombinant protein production, hybridoma, human lymphocyte culture, and insect cell lines; gas permeable cell culture bags and other materials; cryopreservation agent of cells; medium supplements;...
Can you invest in Kohjin Bio Co., Ltd.?
Yes. Kohjin Bio Co., Ltd. trades publicly on JPX as 177A.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Kohjin Bio Co., Ltd.
Detailed equity research is provided by MarketSnap.